New guideline on spasticity in children and young people
The Royal College of Paediatrics and Child Health (RCPCH) – one of the Medicines for Children partners – has endorsed, or supported, the new clinical guideline from the National Institute for Health and Clinical Excellence (NICE) about spasticity in children and young people.
Spasticity affects the muscles, making them more stiff and rigid than usual. It is caused by problems with the part of the brain that controls movement. This guideline makes recommendations about the care and treatment options – including medicines – that should be available on the NHS.
The guideline recommends several medicines for the management of spasticity. Medicines for Children has information leaflets about four of these medicines: